Skip to main content
Equibles

Christal M.M. Mickle

Zevra Therapeutics, Inc. (ZVRA)

CEO

Zevra Therapeutics, Inc. (ZVRA)

Equibles does not estimate personal net worth.

Get an email with a short summary when Zevra Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get ZVRA alerts

About Christal M.M. Mickle

Christal M.M. Mickle is recorded as CEO at Zevra Therapeutics, Inc. (ZVRA) since June 1, 2023. Zevra Therapeutics, Inc. reported in an 8-K filed May 15, 2023 that Christal M.M. Mickle was appointed interim President and Chief Executive Officer, effective June 1, 2023. The proxy statement of Zevra Therapeutics, Inc. reports total compensation of $1,669,956 for Christal M.M. Mickle in fiscal 2023, including a base salary of $435,500. Zevra Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Zevra Therapeutics, Inc. includes Neil F. McFarlane (CEO and Board Member), Richard W. Pascoe (CEO), Matthew R. Plooster (Chairman) and 7 others.

“On May 13, 2023, Zevra’s Board of Directors (the “Board”) appointed Christal M.M. Mickle, Zevra’s Chief Development Officer, as Zevra’s interim President and Chief Executive Officer and (ii) designated Ms. Mickle as Zevra’s principal executive officer, succeeding Richard W. Pascoe, Zevra’s current Chief Executive Officer, in such role, in each case effective as of June 1, 2023 (the “Effective Date”).”
Zevra Therapeutics, Inc. Form 8-K, filed May 15, 2023 · Read the filing

Affiliation history

Company network

Leadership on record at Zevra Therapeutics, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2023 Zevra Therapeutics, Inc. (ZVRA) $435,500 $1,669,956

Recent activity